Simcere is a pharmaceutical company that researches and develops therapeutics for cancer, cardiovascular and bone diseases.
Business Model:
Revenue: $784.5M
Employees: 5,001-10,000
Address: 699-18 Xuanwu Avenue
City: Nanjing
State: jiangsu province
Zip: 210042
Country: CN
Simcere is a pharmaceutical company that researches and develops therapeutics for cancer, cardiovascular and bone diseases.
Contact Phone:
Contact Email:
Listed Exchange:
Hong Kong Stock Exchange
IPO Date:
10/27/2020
Ticker Symbol:
2096
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
10/2022 | Carmine Therapeutics | Series A | - |
10/2016 | Veritas Genetics | Series B | 0 |
2/2020 | Amwise Diagnostic | Series B | 0 |
2/2020 | Amwise Diagnostic | Series B | 0 |
10/2016 | Veritas Genetics | Series B | 0 |
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|